The IJTLD is the reference for clinical research and epidemiological studies on tuberculosis. It is also the only peer-reviewed journal dedicated to lung health worldwide, including articles on TB-HIV and non tuberculosis related respiratory diseases such as asthma, acute respiratory infection, COPD, child lung health and the hazards of tobacco and pollution.
The IJTLD publishes original articles and commissioned reviews on the clinical and biological aspects of pneumology, and on community aspects. With its emphasis on lung health in developing countries, the IJTLD encourages submissions that incorporate: fundamental research, the elaboration, implementation and assessment of field projects and action programmes for tuberculosis control and the promotion of lung health.
The IJTLD welcomes articles on all aspects of lung health, including public health related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research.
Before submission, authors should download the following forms to check that they have complied with requirements
- Instructions for Authors (PDF 202 Ko)
- IJTLD Guidelines for Qualitative Research (PDF 213 Ko)
- Author Checklist (PDF 123 Ko)
- Online Submission Instructions (PDF 168 Ko)
If you experience difficulties of any kind, please don’t hesitate to e-mail the Editorial Office.
Please note that the copyright form (the e-form) must be submitted by the corresponding author online, after article submission. In the event of acceptance all authors will be requested to log on to complete the form online.
The IJTLD is published in both print and electronic formats. It can be viewed online here.
The IJTLD welcomes submissions on COVID-19 and have fast-tracked articles on topical issues, including the potential impact on TB services.
The IJTLD is now inviting authors to submit short articles that improve our understanding of the role that other risk factors – including diabetes, obesity, smoking, air quality, asthma and COPD – have on the impact of COVID-19.